We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CVE:TSXCenovus Energy Inc. Analysis

Data as of 2026-05-15 - not real-time

CA$42.06

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Cenovus Energy (CVE) is trading at CAD 42.06, just shy of its 52‑week high of CAD 42.12 and comfortably above the 20‑day SMA of CAD 38.71, indicating strong short‑term momentum. The 50‑day SMA (CAD 36.24) and 200‑day SMA (CAD 27.53) are well below the current price, reinforcing a bullish trend direction. Technical momentum is further supported by a bullish MACD (line CAD 1.57 above signal CAD 1.42) and a high RSI of 68.7, suggesting the stock is approaching overbought levels. Support sits at CAD 33.71 while resistance is near CAD 42.12, leaving limited upside in the immediate term. Valuation metrics show a trailing PE of 16.8 versus an industry average of 21.5, and a forward PE of 12.1, yet the DCF‑derived fair value of CAD 20.0 is far below the market price, implying the market may be overvaluing the equity. The dividend yield of 2.13% with a modest payout ratio of 32% appears sustainable given strong operating cash flow (CAD 9.1 bn) and free cash flow (CAD 3.7 bn). Recent credit rating improvements from S&P Global, moving the outlook to stable while maintaining a BBB rating, reflect an improved financial risk profile. However, volatility remains elevated at 39% over the past 30 days, and beta is modest, indicating price swings are driven more by sector dynamics than market beta. The consensus analyst recommendation is a “strong buy” with a mean target price of CAD 43.59, suggesting a modest upside of ~3.6% from current levels. Overall, the stock blends solid fundamentals and attractive yield with a potentially stretched valuation and heightened commodity‑related risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (MACD, SMA cross)
  • Price near resistance with limited near‑term upside
  • High RSI indicating potential short‑term pullback

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Improved credit outlook and stable balance sheet
  • Forward PE compression and attractive dividend yield
  • Analyst consensus target price offering modest upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustainable dividend supported by cash flow
  • Exposure to oil‑sand commodity cycles and ESG pressures
  • Valuation gap between market price and DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth-7.10%
Profit Margin9.52%
P/E Ratio16.8
ROE14.83%
ROA5.67%
Debt/Equity42.27
P/B Ratio2.4
Op. Cash FlowCA$9.1B
Free Cash FlowCA$3.7B
Industry P/E21.5

Technical Analysis

TrendBullish
RSI68.7
SupportCA$33.71
ResistanceCA$42.12
MA 20CA$38.71
MA 50CA$36.24
MA 200CA$27.53
MACDBullish
VolumeStable
Fear & Greed Index88.68

Valuation

Fair ValueCA$20.00
Target PriceCA$43.59
Upside/Downside3.65%
GradeOvervalued
TypeBlend
Dividend Yield2.13%

Risk Assessment

Beta-0.01
Volatility39.06%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.